|
|
|
|
|
|||||||
|
Session 104
Poster Session
Perinatal Transmission 4:30-6:30 pm 4E-F |
to view the poster for an abstract.| 788-W. | Evaluation of an Anti-HIV Rapid Test (Determine/Abbott) Offered to Pregnant Women not Tested before Delivery in a Large Public Hospital in Porto Alegre, Brazil B. R. Santos*, I. T. Canti, Y. L. S. Guerin, A. Paqualotto, G. Torre, R. Siege, A. Eichemberg, G. C. Torresini, A. Teixeira, F. Schevittez, and B. Klein Hosp. Nossa Senhora da Conceicao/GHC, Porto Alegre, RS, Brazil
| ||
| 789-W. | Rapid HIV-1 Testing of Pregnant Women Presenting in Labor with Unknown HIV Status in Lima, Peru A. J. Melvin*1, J. Alarcon2, C. Velasquez3, C. Rodriguez3, J. Piscoya2, and L. M. Frenkel1 1Univ. of Washington, Seattle; 2 Univ. Mayor Natl. de San Marcos, Lima, Peru; and 3 Inst. Materno-Perinatal, Lima, Peru
| ||
| 790-W. | Factors Associated with Vertical Transmission in a Cohort of HIV+ Pregnant Women in Rio de Janeiro, Brazil E. C. Joao*, M. L. Cruz, G. Bazin, G. Calvet, L. Salgado, M. d'Ippolito, S. Silva, J. Menezes, and H. Matos Hosp. Servidores do Estado, Rio de Janeiro, Brazil
| ||
| 791-W. | Transmission of HIV-1 Infection between Trophoblast Placental Cells and T Cells Requires LFA-1-Mediated Cell-to-Cell Contact L. Díaz-Muñoz*, R. Alonso-Arias, and M. Munoz-Fernandez Hosp. Gen. Univ. Gregorio Marañón, Madrid, Spain
| ||
| 792-W. | Breastmilk HIV-1 Viral Load Is Associated with Viral Load in Other Compartments, Host Genotype, and Perinatal Transmission C. Rousseau*1, B. Richardson2, M. Steele2, G. John2, R. Nduati3, D. Mbori-Ngacha3, J. Kreiss2, and J. Overbaugh1 1Fred Hutchinson Cancer Res. Ctr., Seattle, WA; 2Univ. of Washington, Seattle; and 3Univ. of Nairobi, Kenya
| ||
| 793-W. | Early Dynamics of RNA Viral Load Levels in HIV-Infected Infants and their Correlations to Maternal RNA Viral Load Around Delivery J. Wiener*1,2, R. Lyles2, E. Abrams3, P. Palumbo4, S. Nesheim2, P. Vink5, and M. Bulterys1 1CDC, Atlanta, GA; 2Emory Univ., Atlanta, GA; 3Harlem Hosp., New York, NY; 4Univ. of Med. and Dentistry of New Jersey, Newark; and 5Univ. of Maryland, Baltimore
| ||
| 794-W. | Pharmacokinetic and Virologic Response to Ritonavir (RTV) in Combination with Zidovudine (ZDV) and Lamivudine (3TC) in HIV-1 Infected Pregnant Women and Their Infants G. Scott*1, J. Rodman2, W. Scott1, D. Shapiro3, S. Huang3, E. Smith4, L. Mofenson4, H. Watts4, and M. J. O’Sullivan1 for the PACTG 354 Protocol Team 1Univ. of Miami Sch.of Med., FL.; 2St. Jude’s Children’s Res. Hosp., Memphis, TN.; 3Harvard Sch. of Publ. Hlth., Boston, MA; and 4NIAID, NIH, Bethesda, MD
| ||
| 795-W. | Pharmacokinetics, Antiviral Activity, and Safety of Nelfinavir (NFV) with ZDV/3TC in Pregnant HIV-Infected Women and Their Infants: PACTG 353 Cohort 2 Y. Bryson*1, A. Stek2,, M. Mirochnick3, L. Mofenson4, J. Connor5, H. Watts4, S. Huang6, M. Hughes6, B. Cunningham7, L. Purdue4, Y. Asfaw8, and E. Smith4 for the PACTG 353 Team 1Univ. of California, Los Angeles; 2Univ. of Southern California, Los Angeles; 3Boston Univ. Sch. of Med, MA; 4NIAID, NIH, Bethesda, MD; 5Univ. of California, San Diego; 6SDAC, Boston, MA; 7FSTRF, Buffalo, NY; and 8PACTG Ops, Rockville, MD
| ||
| 796-W. | Pre-Dose Infant Nevirapine (NVP) Concentration with the 2-Dose Intrapartum (IP)-Infant NVP Regimen M. Mirochnick*1, A. Dorenbaum 2, S. Blanchard 3 , M. J. Werder4, C. Cunningham 5, R. Gelber 3, L. Mofenson6, M. Culnane7, and J. L. Sullivan8 1Boston Univ Sch. of Med., MA; 2 Chiron Corp., Emeryville, CA; 3 Harvard Sch. of Publ. Hlth., Boston, MA; 4FSTRF, Amherst, NY; 5State Univ. of New York, Upstate Med. Univ., Syracuse; 6NICHD, NIH, Rockville, MD; 7NIAID, NIH, Bethesda, MD; and 8Univ. of Massachusetts Med. Sch., Worcester
| ||
| 797-W. | 5-Year Review of Maternal-Fetal Outcomes in Patients Exposed to Indinavir Sulfate during Pregnancy K. McGhee*1, K. Shields1, J. Benson1, P. Beninger1, and R. Sharrar1 for the Antiretroviral Pregnancy Registry (APR)2 1Merck, West Point, PA and 2PharmaRes. Corp., Wilmington, NC
| ||
| 798-W. | Role of Combination Antiretroviral Therapy and Mode of Delivery in Perinatal HIV Transmission (PHT), Pediatric Spectrum of Disease Project (PSD), United States, 1995-2000 J. Patel*1, S. Melville2, C. Heath3, T. Sukalac3, K. Dominguez3, M. G. Fowler3, I. Ortiz4, H. Hsu5, T. Rakusan6, and V. Peters7 for the PSD Consortium8 1Univ. of Texas Med. Branch, Galveston; 2Texas Dept. of Hlth., Austin; 3CDC, Atlanta, GA; 4Dept. de Salud, San Juan, PR; 5State Labs. Inst., Jamaica Plain, MA; 6Children's Natl. Med. Ctr., Washington, DC; 7New York City Dept. of Hlth., NY; and 8PSD Project, U.S.A.
| ||
| 799-W. | Phylogenetic Analysis of Geographic and Temporal Clustering of HIV-1 Isolates Using Third Codon Position Protease and Reverse Transcriptase Sequences from the Women and Infants Transmission Study (WITS) R. Colgrove*1, J. Pitt2,3, G. Bauer4, and S. Welles5 for the WITS Study Group 1Harvard Med. Sch., Boston, MA; 2Columbia Univ., New York, NY; 3Women and Infants Transmission Study (WITS); 4Univ. of Minnesota, Minneapolis; and 5Boston Univ., MA
| ||
| 800-W. | Prevalence of Genotypic Drug Resistance in HIV-Infected Newborns in New York State M. Parker*1, N. Wade1, B. K. Gallagher1, B. Cheku1, R.M. Lloyd Jr2, T. Sullivan1, G. Birkhead1, and J. Taylor1 1New York State Dept. of Hlth., Albany and 2Applied Sci., Inc., Suwanee, GA
| ||
| 801-W. | Comparison of Mother-to-Child Transmission (MTCT) and Genotypic Resistance in HIV-1 Subtypes A, C, and D after Single Dose Nevirapine (sd-NVP) in Africa R. Kantor*1, R. Lloyd2, R. Shafer1, E. Johnston1, L. Guay3, J. B. Jackson3, S. H. Eshleman3, D. Katzenstein1 for the HIVNET 012, and 023 teams 1Stanford Univ., CA; 2Visible Genetics Corp., Suwanee, GA; and 3Johns Hopkins Med. Inst., Baltimore, MD
| ||
| 802-W. | Selection of Resistance Mutations in Pregnant Women Receiving Short-Course Antiretroviral Regimens with ZDV and 3TC to Prevent Perinatal Transmission (PETRA Study) M. Giuliano*1, T. Galluzzo1, R. Amici1, S. Declich1, P. Okong2 , P. Kituuka2, M. Magoni2, L. Palmisano1, D. Bray3, and S. Vella1 1Inst. Superiore di Sanità, Rome, Italy; 2Nsambya Hosp., Kampala, Uganda; and 3GlaxoSmithKline, London, UK
| ||
| 803-W. | Preservation of Thymic Function in Adolescents with Perinatally Acquired HIV-1 Infection T. Pham*1, M. Belzer2, J. Church2, C. Kitchen1, C. Wilson3, S. Douglas4, and P. Krogstad1 1Univ. of California Sch. of Med., Los Angeles; 2Children's Hosp., Los Angeles; 3Univ. of Alabama Sch. of Publ. Hlth., Birmingham; and 4Univ. of Pennsylvania Sch. of Med., Philadelphia
| ||
| 804-W. | Pubertal Development in Children and Adolescents with Perinatally Acquired Human Immunodeficiency Virus (HIV) Infection K. Buchacz*1, A. D. Rogol2, J. C. Lindsey1, C. M. Wilson3, M. D. Hughes1, G. R. Seage III1, J. M. Oleske4, and A. Smith Rogers5 for the Pediatric AIDS Clinical Trials Group 219 Study Team 1Harvard Sch. of Publ. Hlth., Boston, MA; 2Insmed Inc., Glen Allen, VA; 3Univ. of Alabama, Birmingham; 4Univ. of Med. and Dentistry of New Jersey, Newark; and 5NICHD, NIH, Rockville, MD
|
